BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Foegeding NJ, Raghunathan K, Campbell AM, Kim SW, Lau KS, Kenworthy AK, Cover TL, Ohi MD. Intracellular Degradation of Helicobacter pylori VacA Toxin as a Determinant of Gastric Epithelial Cell Viability. Infect Immun 2019;87:e00783-18. [PMID: 30692181 DOI: 10.1128/IAI.00783-18] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Almeida RS, Wisnieski F, Takao Real Karia B, Smith MAC. CRISPR/Cas9 Genome-Editing Technology and Potential Clinical Application in Gastric Cancer. Genes 2022;13:2029. [DOI: 10.3390/genes13112029] [Reference Citation Analysis]
2 Hosseini SA, Jouneghani AS, Ghatrehsamani M, Yaghoobi H, Elahian F, Mirzaei SA. CRISPR/Cas9 as precision and high-throughput genetic engineering tools in gastrointestinal cancer research and therapy. International Journal of Biological Macromolecules 2022. [DOI: 10.1016/j.ijbiomac.2022.11.018] [Reference Citation Analysis]
3 Saxena K, Kumar A, Chauhan N, Khanuja M, Malhotra BD, Jain U. Electrochemical Immunosensor for Detection of H. pylori Secretory Protein VacA on g-C 3 N 4 /ZnO Nanocomposite-Modified Au Electrode. ACS Omega. [DOI: 10.1021/acsomega.2c03627] [Reference Citation Analysis]
4 Palframan SL, Mahmud MT, Tan KS, Grinter R, Xin V, Dunstan RA, Micati D, Kerr G, Mcmurrick PJ, Smith A, Abud H, Nguyen TN, Lazarou M, Kleifeld O, Lithgow T, Cover TL, Gabriel K, Gorrell RJ, Kwok T. Helicobacter pylori vacuolating cytotoxin A exploits human endosomes for intracellular activation.. [DOI: 10.1101/2022.08.22.504206] [Reference Citation Analysis]
5 Zheng L, Wei F, Li G. The crosstalk between bacteria and host autophagy: host defense or bacteria offense. J Microbiol 2022;60:451-460. [DOI: 10.1007/s12275-022-2009-z] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Ansari S, Yamaoka Y. Helicobacter pylori Infection, Its Laboratory Diagnosis, and Antimicrobial Resistance: a Perspective of Clinical Relevance. Clin Microbiol Rev 2022;:e0025821. [PMID: 35404105 DOI: 10.1128/cmr.00258-21] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Aydin S, Ozkul C, Yucel NT, Karaca H. Gut Microbiome Alteration after Reboxetine Administration in Type-1 Diabetic Rats. Microorganisms 2021;9:1948. [PMID: 34576843 DOI: 10.3390/microorganisms9091948] [Reference Citation Analysis]
8 Singh P, Tiwari SP, Mehdi MM, Sharma R. Role of Bacterial Infection (H. pylori) in Colon Carcinogenesis and Therapeutic Approaches. Colon Cancer Diagnosis and Therapy 2021. [DOI: 10.1007/978-3-030-64668-4_6] [Reference Citation Analysis]
9 Baj J, Forma A, Sitarz M, Portincasa P, Garruti G, Krasowska D, Maciejewski R. Helicobacter pylori Virulence Factors-Mechanisms of Bacterial Pathogenicity in the Gastric Microenvironment. Cells 2020;10:E27. [PMID: 33375694 DOI: 10.3390/cells10010027] [Cited by in Crossref: 51] [Cited by in F6Publishing: 56] [Article Influence: 25.5] [Reference Citation Analysis]
10 Caston RR, Sierra JC, Foegeding NJ, Truelock MD, Campbell AM, Frick-Cheng AE, Bimczok D, Wilson KT, McClain MS, Cover TL. Functional Properties of Helicobacter pylori VacA Toxin m1 and m2 Variants. Infect Immun 2020;88:e00032-20. [PMID: 32284370 DOI: 10.1128/IAI.00032-20] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
11 Chmiela M, Kupcinskas J. Review: Pathogenesis of Helicobacter pylori infection. Helicobacter 2019;24 Suppl 1:e12638. [PMID: 31486234 DOI: 10.1111/hel.12638] [Cited by in Crossref: 28] [Cited by in F6Publishing: 36] [Article Influence: 9.3] [Reference Citation Analysis]